Prevention of lipopolysaccharide-induced mouse lethality by resveratrol

Food and Chemical Toxicology

Volumn 48, Issue 6, 2010, Pages 1543-1549

  Sebai, Hichem ^a,b   Sani, Mamane ^c   Ghanem Boughanmi, Néziha ^d   Aouani, Ezzedine ^d  

^a University of Carthage   (Tunisia)

^b University of Jendouba   (Tunisia)

^c Faculte des Sciences de la Sante   (Niger)

^d CENTRE DE BIOTECHNOLOGIE DE BORJ CÉDRIA   (Tunisia)

Author keywords

Iron; Lethality; Lipopolysaccharide; Nitric Oxide; Oxidative stress; Resveratrol

Indexed keywords

AMINOTRANSFERASE; CATALASE; CREATININE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IRON; MALONALDEHYDE; NITRIC OXIDE; RESVERATROL; UREA;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; KIDNEY DYSFUNCTION; KIDNEY HOMOGENATE; LETHALITY; LIPID PEROXIDATION; LIVER DYSFUNCTION; LIVER HOMOGENATE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIMARY PREVENTION; SEPTIC SHOCK; SURVIVAL RATE; UREA BLOOD LEVEL;

ANIMALS; CATALASE; IRON; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; MALE; MICE; NITRIC OXIDE; OXIDATIVE STRESS; STILBENES;

ANIMALIA; MUS;

EID: 77952879593     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.03.022     Document Type: Article

References (43)

1. Aebi H. Catalase in vitro. Methods in Enzymology 1984, 105:121-126.
2. Alpert P.T. New and emerging theories of cardiovascular disease: infection and elevated iron. Biological Research for Nursing 2004, 6:3-10.
3. Andrews N.C. Disorders of iron metabolism. The New England Journal for Medicine 1999, 341:1986-1995.
4. Bi X.L., Yang J.Y., Dong Y.S., Wang J.M., Cui Y.H., Ikeshima T., Zhao Y.Q., Wu C.F. Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. International Immunopharmacology 2005, 5:185-193.
5. Bujanda L., García-Barcina M., Gutiérrez-de Juan V., Bidaurrazaga J., de Luco M.F., Gutiérrez-Stampa M., Larzabal M., Hijona E., Sarasqueta C., Echenique-Elizondo M., Arenas J.I. Effect of resveratrol on alcohol-induced mortality and liver lesions in mice. BMC Gastroenterology 2006, 6:35.
6. Castellani R.J., Moreira P.I., Liu G., Dobson J., Perry G., Smith M.A., Zhu X. Iron: the Redox-active center of oxidative stress in Alzheimer disease. Neurochemical Research 2007, 32:1640-1645.
7. Chander V., Tirkey N., Chopra K. Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism. Toxicology 2005, 210:55-64.
8. Das S., Fraga C.G., Das D.K. Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB. Free Radical Research 2006, 40:1066-1075.
9. Delalastra C.A., Villegas I. Resveratrol as an antioxidant and prooxidant agent: mechanisms and clinical implication. Biochemical Society Transactions 2007, 35:1156-1160.
10. Devireddy L.R., Gazin C., Zhu X., Green M.R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 2005, 123:1293-1305.
11. Ding W.Q., Liu B., Vaught J.L., Yamauchi H., Lind S.E. Anticancer activity of the antibiotic clioquinol. Cancer Research 2005, 65:3389-3395.
12. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods in Enzymology 1990, 186:421-431.
13. Freudenberg M.A., Galanos C. Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action. International Reviews of Immunology 1990, 6:207-221.
14. Gadacha W., Ben-Attia M., Bonnefont-Rousselot D., Aouani E., Ghanem-Boughanmi N., Touitou Y. Resveratrol opposite effects on rat tissue lipoperoxidation: pro-oxidant during day-time and antioxidant at night. Redox Report 2009, 14:1-5.
15. Green L.C., Wagner D.A., Glogowski J., Shipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Analytical Biochemistry 1982, 126:131-138.
16. Hartree E.F. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Analytical Biochemistry 1972, 48:422-427.
17. Hobbs A.J., Higgs A., Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annual Review of Pharmacology and Toxicology 1999, 39:191-220.
18. Hung L.M., Chen J.K., Huang S.S., Lee R.S., Su M.J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovascular Research 2000, 47:549-555.
19. Isobe H., Okajima K., Uchiba M., Mizutani A., Harada N., Nagasaki A., Okabe K. Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 2001, 104:1171-1175.
20. Kitajima S., Tsuda M., Eshita N., Matsushima Y., Saitoh M., Momma J., Kurokawa Y. Lipopolysaccharide-associated elevation of serum and urinary nitrite/nitrate levels and hematological changes in rats. Toxicology Letters 1995, 78:135-140.
21. Kruzel M.L., Harari Y., Mailman D., Actor J.K., Zimecki M. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clinical and Experimental Immunology 2002, 130:25-31.
22. Leardi A., Caraglia M., Selleri C., Pepe S., Pizzi C., Notaro R., Fabbrocini A., De Lorenzo S., Musicò M., Abbruzzese A., Bianco A.R., Tagliaferri P. Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. British Journal of Haematology 1998, 102:746-752.
23. Ma Z.H., Ma Q.Y., Wang L.C., Sha H.C., Wu S.L., Zhang M. Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis. Inflammation Research 2005, 54:522-527.
24. Mallis R.J., Buss J.E., Thomas J.A. Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. The Biochemical Journal 2001, 355:145-153.
25. Mokni M., Elkahoui S., Limam F., Amri M., Aouani E. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochemical Research 2007, 32:981-987.
26. Mokni M., Limam F., Elkahoui S., Amri M., Aouani E. Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. Archives of Biochemistry and Biophysics 2007, 457:1-6.
27. Nakada J., Matsura T., Okazaki N., Nishida T., Togawa A., Minami Y., Inagaki Y., Ito H., Yamada K., Ishibe Y. Oral administration of geranylgeranylacetone improves survival rate in a rat endotoxin shock model: administration timing and heat shock protein 70 induction. Shock 2005, 24:482-487.
28. Peyssonnaux C., Zinkernagel A.S., Datta V., Lauth X., Johnson R.S., Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 2006, 107:3727-3732.
29. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., Loréal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. Journal of Biological Chemistry 2001, 276:7811-7819.
30. Saito M., Satoh S., Kojima N., Tada H., Sato M., Suzuki T., Senoo H., Habuchi T. Effects of a phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 expression in rat kidneys with ischemia/reperfusion injury. Archives of Histology and Cytology 2005, 68:41-49.
31. Sebai H., Ben-Attia M., Sani M., Aouani E., Ghanem-Boughanmi N. Protective effect of resveratrol on acute endotoxemia-induced nephrotoxicity in rat through nitric oxide independent mechanism. Free Radical Research 2008, 42:913-920.
32. Sebai H., Ben-Attia M., Sani M., Aouani E., Ghanem-Boughanmi N. Protective effect of resveratrol in endotoxemia-induced acute phase response in rats. Archives of Toxicology 2009, 83:335-340.
33. Sebai H., Gadacha W., Sani M., Aouani E., Ghanem-Boughanmi N., Ben-Attia M. Protective effect of resveratrol against lipopolysaccharide-induced oxidative stress in rat brain. Brain Injury 2009, 23:1089-1094.
34. Sebai, H., Sani, M., Yacoubi, M.T., Aouani, E., Ghanem-Boughanmi, N., Ben-Attia, M., in press. Resveratrol, a red wine polyphenol, attenuates lipopolysaccharide-induced oxidative stress in rat liver. Ecotoxicology and Environmental Safety.
35. Soleas G.J., Diamandis E.P., Goldgerg D.M. Resveratrol: a molecule whose time has come? and gone?. Clinical Biochemistry 1997, 30:91-113.
36. Sunil V.R., Patel K.J., Nilsen-Hamilton M., Heck D.E., Laskin J.D., Laskin D.L. Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Experimental and Molecular Pathology 2007, 83:177-187.
37. Tsai S.K., Hung L.M., Fu Y.T., Cheng H., Nien M.W., Liu H.Y., Zhang F.B., Huang S.S. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. Journal of Vascular Surgery 2007, 46:346-353.
38. Tunctan B., Uludag O., Altug S., Abacioglu N. Effect of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. Pharmacological Research 1998, 38:405-411.
39. Uchiyama A., Kim J.S., Kon K., Jaeschke H., Ikejima K., Watanabe S., Lemasters J.J. Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury. Hepatology 2008, 48:1644-1654.
40. Wang S., Wang X., Yan J., Xie X., Fan F., Zhon X., Han L., Chen J. Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway. European Journal of Pharmacology 2007, 567:26-35.
41. Westphal M., Stubbe H., Sielenkämper A.W., Borgulya R., Van Aken H., Ball C., Bone H.G. Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Medicine 2003, 29:154-155.
42. Yeh K.Y., Yeh M., Glass J. Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat. American Journal of Physiology. Gastrointestinal and Liver Physiology 2004, 286:385-394.
43. Zhuang H., Kim Y.S., Koehler R.C., Doré S. Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Annals of the New York Academy of Sciences 2003, 993:276-286.